RLAY
Relay Therapeutics Inc.
Company Overview
| Mkt Cap | $803.44M | Price | $7.14 |
| Volume | 1.45M | Change | -2.72% |
| P/E Ratio | -2.4 | Open | $7.33 |
| Revenue | $10.0M | Prev Close | $7.34 |
| Net Income | $-337.7M | 52W Range | $1.78 - $7.64 |
| Div Yield | N/A | Target | $13.60 |
| Overall | 56 | Value | 60 |
| Quality | 44 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyRelay Therapeutics Inc. (RLAY) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $7.14 with a market capitalization of $803.44 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows RLAY with a volume of 1.45 million shares. The stock opened down 0.14% from yesterday's close of $7.34. Current analyst estimates project earnings of $-1.59 per share for this year, with next year targeting $-1.52.
RLAY demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RLAY include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 90.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLAY | $7.14 | -2.7% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |